Clinical trial
Pentoxifylline Dose Optimization in Preterm Neonatal Late Onset Sepsis
NCT04152980 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pentoxifylline Dose Optimization in Preterm Neonatal Late Onset Sepsis
- Lead sponsor
- Erasmus Medical Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 12, 2020
- Completion date
- December 31, 2022
- Enrollment
- 30 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
neonatal late onset sepsis